StockNews.com assumed coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a research note released on Friday. The firm issued a sell rating on the stock. OCX has been the subject of several other reports. Benchmark reduced their price target on OncoCyte from $9.00 to $5.00 and set a speculative buy rating for the […]
StockNews.com started coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a research report released on Saturday. The firm issued a sell rating on the stock. Several other research analysts also recently weighed in on OCX. Needham & Company LLC dropped their target price on shares of OncoCyte from $4.25 to $3.60 and set […]
StockNews.com initiated coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a research report sent to investors on Sunday morning. The brokerage issued a sell rating on the stock. Other equities research analysts have also issued research reports about the stock. Benchmark reduced their price objective on shares of OncoCyte from $9.00 to $5.00 […]
StockNews.com began coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a report published on Sunday morning. The brokerage issued a sell rating on the stock. OCX has been the subject of a number of other reports. Needham & Company LLC dropped their price objective on OncoCyte from $4.25 to $3.60 and set a […]
Equities research analysts at StockNews.com began coverage on shares of OncoCyte (NASDAQ:OCX – Get Free Report) in a research note issued on Monday. The firm set a “sell” rating on the stock. A number of other equities research analysts also recently issued reports on the stock. Needham & Company LLC reduced their price target on […]